AEBP2
Zinc finger protein AEBP2
Also known as: AEBP2_HUMAN, MGC17922
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6ZN18
- Gene
- AEBP2
- Ensembl
- ENSG00000139154
- Chromosome
- 12
- Canonical length
- 517 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Predicted to enable DNA binding activity; transcription coregulator activity; and zinc ion binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to act upstream of or within regulation of DNA-templated transcription. Located in nucleoplasm. Part of ESC/E(Z) complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
517 residues, UniProt reviewed canonical sequence.
>Q6ZN18|AEBP2
1 MAAAITDMAD LEELSRLSPL PPGSPGSAAR GRAEPPEEEE EEEEEEEEAE AEAVAALLLN
61 GGSGGGGGGG GGGVGGGEAE TMSEPSPESA SQAGEDEDEE EDDEEEEDES SSSGGGEEES
121 SAESLVGSSG GSSSDETRSL SPGAASSSSG DGDGKEGLEE PKGPRGSQGG GGGGSSSSSV
181 VSSGGDEGYG TGGGGSSATS GGRRGSLEMS SDGEPLSRMD SEDSISSTIM DVDSTISSGR
241 STPAMMNGQG STTSSSKNIA YNCCWDQCQA CFNSSPDLAD HIRSIHVDGQ RGGVFVCLWK
301 GCKVYNTPST SQSWLQRHML THSGDKPFKC VVGGCNASFA SQGGLARHVP THFSQQNSSK
361 VSSQPKAKEE SPSKAGMNKR RKLKNKRRRS LPRPHDFFDA QTLDAIRHRA ICFNLSAHIE
421 SLGKGHSVVF HSTVIAKRKE DSGKIKLLLH WMPEDILPDV WVNESERHQL KTKVVHLSKL
481 PKDTALLLDP NIYRTMPQKR LKRTLIRKVF NLYLSKQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against AEBP2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.58
- Highest tissue expression
- 41 nTPM
Expression across tissuesHPA
Tissue
- placenta: 41 nTPM
- blood vessel: 37 nTPM
- esophagus: 33 nTPM
- endometrium: 32 nTPM
- ovary: 31 nTPM
- tonsil: 30 nTPM
Single-cell type
- choroid plexus epithelial cells: 455 nCPM
- brain excitatory neurons: 387 nCPM
- retinal ganglion cells: 375 nCPM
- ependymal cells: 373 nCPM
- other brain neurons: 347 nCPM
- distal convoluted tubule cells: 335 nCPM
Immune cell
- NK-cell: 6 nTPM
- naive CD8 T-cell: 5.8 nTPM
- T-reg: 4.5 nTPM
- MAIT T-cell: 4.4 nTPM
- memory CD4 T-cell: 4.4 nTPM
- basophil: 4.3 nTPM
Brain region
- hippocampal formation: 118 nTPM
- cerebral cortex: 116 nTPM
- white matter: 110 nTPM
- hypothalamus: 105 nTPM
- choroid plexus: 103 nTPM
- cerebellum: 103 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about AEBP2.
Disease | ImmuneIEDB
Conditions an epitope on AEBP2 was assayed in.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.14
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.21
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- chromatin organization
- negative regulation of transcription by RNA polymerase II
- regulation of transcription by RNA polymerase II
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Zinc finger C2H2-type
- Zinc finger C2H2 superfamily
- AEBP2/jing C2H2-type zinc-finger
- AEBP2-like, C-terminal SH3 domain
- AEBP2-like, C-terminal SH3 domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of AEBP2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AEBP2 as an antibody target. Whether an autoantibody or antibody against AEBP2 could matter depends on whether native AEBP2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AEBP2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label AEBP2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...